In the hematology departments of our network’s esteemed hospitals, patients benefit from the forefront of medical innovation with the application of cutting-edge drugs for chemotherapy, immunotherapy, and biotherapy. The department’s treatment success rates are among the highest in the word.

When it comes to the treatment of hematopoietic system cancer by bone marrow transplantation, we are working with the global leaders in this field.

Up to 80% of patients diagnosed with lymphoma and up to 95% of leukemia patients are completely cured here (the percentage of success depends on the type of tumor). This is a very high rate, one of the best in the Middle East and Europe.

The main types of diseases that are successfully diagnosed and treated in the Department of Hematology:

  • different types of leukemia;
  • different types of lymphomas;
  • myeloma;
  • blood clotting disorders and hereditary blood diseases;
  • thrombocytopenia (low level of platelets in the blood);
  • anemia;
  • disorders of the hemostasis system;
  • thalassemia;
  • hemoglobinopathy;
  • myelodysplasia;
  • lymphoproliferative conditions.

The Hematology department combines all necessary elements to achieve accurate diagnose and high-level treatment results, such as:

  • The medical team of the department consists of leading hematologists;
  • Innovative drugs;
  • Modern diagnostic methods based on molecular biology and immunofluorescence.

The latest immunotherapy drugs in oncologic hematology

In the treatment of myeloma and various types of lymphomas, oncologic hematologists within our network of hospitals utilize the latest generation of immunotherapy drugs, such as:

  • proteasome inhibitors that block the creation of a cell-destroying protein.
  • immunomodulators that do not directly affect the tumor, but cause an immune response of cells.
  • monoclonal antibodies (elotuzumab, daratumumab, isatuximab) that bind to cell-destroying proteins and cause an immune system response.

Doctors achieve the greatest effect with an individually selected combination of drugs for each patient.

Posted by:

Anna_Gutenderg Anna Gutenberg